European Medicines Agency (EMA) : EMAs Pharmacovigilance Risk Assessment Committee reviewed clinical trial data, post-marketing reports, and published literature and concluded that NAION should be added as a very rare side effect of semaglutide medicines
It treats that as a reason for closer provider assessment rather than an automatic exclusion
Animal studies by Carla Nasca, a postdoctoral scholar in McEwens lab, suggest that acetyl-L-carnitine, a crucial mediator of fat metabolism and energy production throughout the body, plays a special role in the brain, where it works at least in part by preventing the excessive firing of excitatory nerve cells in brain regions called the hippocampus and frontal cortex
Anti-inflammatory Effects Reduces Systemic Inflammation: Decreases inflammation throughout the body
No, the GLP-1 medication itself will not appear on standard blood tests because routine panels do not measure peptide agonists